{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["antidepressants", "antipsychotics", "anxiolytics", "hypnotics", "insomnia", "polypharmacy", "psychotropic drugs"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37946602", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "15"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "11", "Day": "09"}], "ELocationID": ["10.1002/npr2.12386"], "Journal": {"ISSN": "2574-173X", "JournalIssue": {"Volume": "44", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Neuropsychopharmacology reports", "ISOAbbreviation": "Neuropsychopharmacol Rep"}, "ArticleTitle": "Trends in the multiple prescriptions of hypnotic drugs in a university outpatient in Japan.", "Pagination": {"StartPage": "80", "EndPage": "89", "MedlinePgn": "80-89"}, "Abstract": {"AbstractText": ["In Japan, the daily dosage of hypnotic drugs for insomnia treatment is increasing year by year, and over-dependence on treatment with hypnotic drugs is a major problem. This study aimed to examine the factors related to the elimination of prescriptions of three or more hypnotic drugs within 1\u2009year in our clinic.", "We conducted two surveys. Survey \u2460 assessed the frequency of prescriptions of three or more hypnotic drugs by retrospectively reviewing the medical records of all patients who visited general and psychiatric outpatient clinics from January 2013 to March 2019. Survey \u2461 assessed changes in prescriptions of hypnotic and psychotropic drugs within the subsequent year by retrospectively reviewing the medical records of all patients prescribed three or more hypnotic drugs who visited neuropsychiatric outpatient clinics multiple times between April 2013 and March 2019.", "The frequency of prescribing three or more hypnotic drugs was six to nine times higher in psychiatry than in other departments. Flunitrazepam and brotizolam were the most common drugs prescribed and had the second lowest discontinuation rate after zolpidem. Conversely, eszopiclone, zopiclone, and suvorexant had the highest discontinuation rates. The success factors for drug reduction were age (odds ratio [OR]: 0.97, p\u2009<\u20090.0037), trazodone addition (OR: 12.86, p\u2009<\u20090.0194) and number of years of psychiatric experience.", "The characteristics and success factors in relation to drug reduction in patients with multiple prescriptions of hypnotic drugs identified in this study may contribute to solving the problem of multiple prescriptions of hypnotic drugs."], "CopyrightInformation": "\u00a9 2023 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology."}, "AuthorList": [{"Identifier": ["0000-0001-9404-5020"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}, {"Identifier": [], "Affiliation": "Department of Psychiatry, Kato Hospital, Kisarazu, Japan."}], "LastName": "Kato", "ForeName": "Takao", "Initials": "T"}, {"Identifier": ["0000-0002-0676-1754"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}, {"Identifier": [], "Affiliation": "Department of Psychiatry, Kotorii Isahaya Hospital, Nagasaki, Japan."}], "LastName": "Kotorii", "ForeName": "Nozomu", "Initials": "N"}, {"Identifier": ["0000-0003-1738-3629"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Ozone", "ForeName": "Motohiro", "Initials": "M"}, {"Identifier": ["0000-0003-0623-9365"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biostatistics Center, Kurume University, Fukuoka, Japan."}], "LastName": "Murotani", "ForeName": "Kenta", "Initials": "K"}, {"Identifier": ["0000-0003-0759-5636"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Ohshima", "ForeName": "Hayato", "Initials": "H"}, {"Identifier": ["0000-0002-5074-4943"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Mori", "ForeName": "Hiroyuki", "Initials": "H"}, {"Identifier": ["0000-0003-3125-4620"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Wasano", "ForeName": "Kenjirou", "Initials": "K"}, {"Identifier": ["0000-0002-0936-4383"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Hiejima", "ForeName": "Hiroshi", "Initials": "H"}, {"Identifier": ["0000-0002-0971-6668"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Habukawa", "ForeName": "Mitsunari", "Initials": "M"}, {"Identifier": ["0000-0002-9177-4049"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neuropsychiatry, Kurume University School of Medicine, Fukuoka, Japan."}], "LastName": "Uchimura", "ForeName": "Naohisa", "Initials": "N"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Neuropsychopharmacol Rep", "NlmUniqueID": "101719700", "ISSNLinking": "2574-173X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hypnotics and Sedatives"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Outpatients"}, {"QualifierName": [], "DescriptorName": "Japan"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": [], "DescriptorName": "Universities"}, {"QualifierName": [], "DescriptorName": "Drug Prescriptions"}, {"QualifierName": [], "DescriptorName": "Hypnotics and Sedatives"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Buysse DJ. Chronic insomnia. Am J Psychiatry. 2008;165:678\u2013686.", "ArticleIdList": ["PMC2859710", "18519533"]}, {"Citation": "Pigeon WR, Perlis ML. Sleep homeostasis in primary insomnia. Sleep Med Rev. 2006;10:247\u2013254.", "ArticleIdList": ["16563817"]}, {"Citation": "Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta\u2010analysis. Diabetes Care. 2010;33:414\u2013420.", "ArticleIdList": ["PMC2809295", "19910503"]}, {"Citation": "Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435\u20131439.", "ArticleIdList": ["10543671"]}, {"Citation": "Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et\u00a0al. Insomnia as a predictor of depression: a meta\u2010analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10\u201319.", "ArticleIdList": ["21300408"]}, {"Citation": "Mishima K, Riemann D. A survey study on psychotropics prescription using medical fee data. Health and Labor Sciences Research Grant and Health and Labor Sciences Special Research Project \u201cComparative Research on the Prescription Status of Psychotropic Drugs in Japan and Overseas\u201d 2010 Research Report. 2011, pp. 15\u201332."}, {"Citation": "Okumura Y, Inada K, Matsumoto T. Clinical psychopharmacology of changes in high\u2010dose and multi\u2010drug prescriptions of antianxiety drugs and hypnotics due to revision of medical treatment fees. J Clin Psychopharmacol. 2015;18:11173\u201311188."}, {"Citation": "Katz MH. Multivariable analysis. A practical guide for clinicians second edition. Cambridge: Cambridge University Press; 2006."}, {"Citation": "R Core Team . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021."}, {"Citation": "Rickels K, Case WG, Schweizer EE, Garcia F, Fridman R. Long\u2010term benzodiazepine users 3\u2009years after participation in a discontinuation program. Am J Psychiatry. 1991;148:757\u2013761.", "ArticleIdList": ["2035717"]}, {"Citation": "Holton A, Riley P, Tyrer P. Factors predicting long\u2010term outcome after chronic benzodiazepine therapy. J Affect Disord. 1992;24:245\u2013252.", "ArticleIdList": ["1578080"]}, {"Citation": "Rickels K, Schweizer E, Case WG, Greenblatt DJ. Long\u2010term therapeutic of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry. 1990;47:899\u2013907.", "ArticleIdList": ["2222129"]}, {"Citation": "Schweizer E, Rickels R, De Martinis N, Case G, Garcia\u2010Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychol Med. 1998;28:713\u2013720.", "ArticleIdList": ["9626727"]}, {"Citation": "Rickels K, DeMartinis N, Garcia\u2010Espana F, Greenblat DJ, Mandos LA, Rynn M. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long\u2010term benzodiazepine therapy. Am J Psychiatry. 2000;157:1973\u20131979.", "ArticleIdList": ["11097963"]}, {"Citation": "Murphy SM, Tyrer P. A double\u2010blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiatry. 1991;158:511\u2013516.", "ArticleIdList": ["1675901"]}, {"Citation": "Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. Br J Addict. 1987;82:665\u2013671.", "ArticleIdList": ["2886145"]}, {"Citation": "Golombok S, Higgitt A, Fonagy P, Dodds S, Saper J, Lader M. A follow\u2010up study of patients treated for benzodiazepine dependence. Br J Med Psychol. 1987;60:141\u2013149.", "ArticleIdList": ["2887197"]}, {"Citation": "Mishima K. FY2017\u201029 Comprehensive Research Project on Policies for Persons with Disabilities, \u201cResearch on Guidelines for Pharmacotherapy to Elucidate the Psychotropic Drug Prescription and Practice Appropriate Prescription (H291 Psychiatry 1101)\u201d Shared Research Report. 2017."}, {"Citation": "Arakawa R. Investigation of prescription status of antianxiety drugs and hypnotics in outpatient care using a national database. Clin Psychiat. 2015;44:1003\u20131010."}, {"Citation": "Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta\u2010analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162:225\u2013233.", "ArticleIdList": ["PMC1232276", "10674059"]}, {"Citation": "Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta\u2010analysis of risks and benefits. BMJ. 2005;331:1169.", "ArticleIdList": ["PMC1285093", "16284208"]}, {"Citation": "Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999\u20132010. Sleep. 2014;37:343\u2013349.", "ArticleIdList": ["PMC3900622", "24497662"]}, {"Citation": "Jaffer YK, Chang T, Vanle B, Dang J, Steiner AJ, Loera N, et\u00a0al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14:24\u201334.", "ArticleIdList": ["PMC5842888", "29552421"]}, {"Citation": "Doroudgar S, Chou TI, Yu J, Trinh K, Pal J, Perry PJ. Evaluation of trazodone and quetiapine for insomnia: an observational study in psychiatric inpatients. Prim Care Companion CNS Disord. 2013;15:13m01558.", "ArticleIdList": ["PMC3977773", "24800124"]}, {"Citation": "Rickels K, Case WG, Schweizer EE, Swenson C, Fridman RB. Low\u2010dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients. Psychopharmacol Bull. 1986;22:407\u2013415.", "ArticleIdList": ["2877472"]}, {"Citation": "Hallfors DD, Saxe L. The dependence potential of short half\u2010life benzodiazepines: a meta\u2010analysis. Am J Public Health. 1993;83:1300\u20131304.", "ArticleIdList": ["PMC1694983", "8103297"]}, {"Citation": "Nutt DJ, Stahl SM. Search for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2010;24:1601\u20131612.", "ArticleIdList": ["19942638"]}, {"Citation": "Frankle WG, Cho RY, Prasad KM, Mason NS, Paris J, Himes ML, et\u00a0al. In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients. Am J Psychiatry. 2015;172:1159\u20131178.", "ArticleIdList": ["PMC5070491", "26133962"]}, {"Citation": "Matsumoto T, Ozaki S, Kobayashi S, Wada K. Current situation and clinical characteristics of sedative\u2010related disorder patients in Japan: a comparison with methamphetamine\u2010related disorder patients. Psychiatr Mag. 2011;113:1184\u20131198.", "ArticleIdList": ["22352004"]}, {"Citation": "Matsumoto T, Ito T, Takano T. A survey of the actual conditions of drug\u2010related psychiatric disorders in psychiatric care facilities nationwide. FY2016 Health, Labour and Welfare Science Research Grant (Research Report on Regulatory Science Policy Research Projects for Pharmaceuticals and Medical Devices). 2017."}, {"Citation": "Matsumoto T, Naruse N, Umeno M. A study on the clinical characteristics of benzodiazepine use disorders and the characteristics of psychiatric treatment that triggered the onset. J Jpn Soc Alc Pharm Med. 2012;47:317\u2013330.", "ArticleIdList": ["23461220"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "19"}, {"Year": "2023", "Month": "2", "Day": "9"}, {"Year": "2023", "Month": "10", "Day": "3"}, {"Year": "2024", "Month": "3", "Day": "14", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "11", "Day": "10", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "10", "Hour": "3", "Minute": "46"}, {"Year": "2023", "Month": "11", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37946602", "PMC10932787", "10.1002/npr2.12386"]}}], "PubmedBookArticle": []}